Novus Therapeutics (NVUS) Announces Acquisition of Anelixis Therapeutics in Stock-for-Stock Deal Sep 14, 2020 04:32PM
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics Sep 14, 2020 04:31PM
UPDATE: Ladenburg Thalmann Downgrades Novus Therapeutics, Inc (NVUS) to Neutral Jun 2, 2020 06:48AM
Novus Therapeutics (NVUS) Phase 2a Trial of OP0201 in Acute Otitis Media Did Not Achieve Statistical Significance for Primary Efficacy Endpoints Jun 1, 2020 08:33AM
Novus Therapeutics Announces Topline Results of Phase 2a Clinical Trial of OP0201 in Acute Otitis Media Jun 1, 2020 08:30AM


Aug 29, 2019 08:30AM Novus Therapeutics to Participate in Two Upcoming Investor Conferences
Sep 26, 2018 08:30AM Novus Therapeutics to Present at the Ladenburg Thalmann 2018 Healthcare Conference
Sep 11, 2018 06:45AM Ladenburg Thalmann Starts Novus Therapeutics, Inc (NVUS) at Buy
Sep 4, 2018 04:08PM Novus Therapeutics (NVUS) Announces Proposed 6M Share Common Offering
Sep 4, 2018 04:05PM Novus Therapeutics Announces Proposed Public Offering of Common Stock